1.30
price down icon2.99%   -0.04
after-market After Hours: 1.31 0.01 +0.77%
loading
Outlook Therapeutics Inc stock is traded at $1.30, with a volume of 938.30K. It is down -2.99% in the last 24 hours and up +33.86% over the past month. Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
See More
Previous Close:
$1.34
Open:
$1.34
24h Volume:
938.30K
Relative Volume:
0.25
Market Cap:
$57.75M
Revenue:
-
Net Income/Loss:
$-51.50M
P/E Ratio:
-0.325
EPS:
-4
Net Cash Flow:
$-47.10M
1W Performance:
-2.99%
1M Performance:
+33.86%
6M Performance:
-16.13%
1Y Performance:
-75.33%
1-Day Range:
Value
$1.28
$1.34
1-Week Range:
Value
$1.27
$1.48
52-Week Range:
Value
$0.79
$6.98

Outlook Therapeutics Inc Stock (OTLK) Company Profile

Name
Name
Outlook Therapeutics Inc
Name
Phone
(609) 619-3990
Name
Address
111 S. WOOD AVENUE, ISELIN, NJ
Name
Employee
23
Name
Twitter
Name
Next Earnings Date
2024-08-14
Name
Latest SEC Filings
Name
OTLK's Discussions on Twitter

Compare OTLK with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
OTLK
Outlook Therapeutics Inc
1.30 62.63M 0 -51.50M -47.10M -4.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.63 109.29B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.00 62.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.69 61.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.18 51.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.03 34.68B 4.56B -176.77M 225.30M -1.7177

Outlook Therapeutics Inc Stock (OTLK) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-29-25 Downgrade H.C. Wainwright Buy → Neutral
Aug-28-25 Downgrade Guggenheim Buy → Neutral
Dec-02-24 Downgrade Chardan Capital Markets Buy → Neutral
Mar-27-24 Upgrade BTIG Research Neutral → Buy
Feb-15-24 Upgrade Chardan Capital Markets Neutral → Buy
Jan-25-24 Upgrade Guggenheim Neutral → Buy
Dec-27-23 Upgrade CapitalOne Equal Weight → Overweight
Aug-31-23 Downgrade Chardan Capital Markets Buy → Neutral
Aug-31-23 Downgrade H.C. Wainwright Buy → Neutral
Aug-30-23 Downgrade BTIG Research Buy → Neutral
Aug-30-23 Downgrade Cantor Fitzgerald Overweight → Neutral
Aug-30-23 Downgrade CapitalOne Overweight → Equal Weight
Aug-30-23 Downgrade Guggenheim Buy → Neutral
Jul-13-23 Initiated CapitalOne Overweight
Apr-03-23 Initiated Guggenheim Buy
Feb-06-23 Initiated Cantor Fitzgerald Overweight
Oct-31-22 Initiated BTIG Research Buy
Sep-13-22 Initiated Chardan Capital Markets Buy
Sep-11-19 Initiated Ladenburg Thalmann Buy
May-16-19 Initiated Oppenheimer Outperform
Apr-22-19 Initiated Ascendiant Capital Markets Buy
View All

Outlook Therapeutics Inc Stock (OTLK) Latest News

pulisher
07:43 AM

What technical models suggest about Outlook Therapeutics Inc.’s comeback - newser.com

07:43 AM
pulisher
06:54 AM

Outlook Therapeutics Inc. stock prediction for this week2025 Price Targets & AI Forecast Swing Trade Picks - newser.com

06:54 AM
pulisher
06:02 AM

Is Outlook Therapeutics Inc. (41O) stock bottoming after sell off2025 Analyst Calls & Fast Moving Market Watchlists - newser.com

06:02 AM
pulisher
05:24 AM

Can Outlook Therapeutics Inc. stock beat analyst upgradesGlobal Markets & Real-Time Buy Zone Alerts - newser.com

05:24 AM
pulisher
03:40 AM

Will Outlook Therapeutics Inc. (41ON) stock outperform value peersProduct Launch & Technical Buy Zone Confirmation - newser.com

03:40 AM
pulisher
02:54 AM

How to read the order book for Outlook Therapeutics Inc.2025 Technical Patterns & Expert Approved Momentum Ideas - newser.com

02:54 AM
pulisher
02:39 AM

Is Outlook Therapeutics Inc. (41ON) stock good for long term investing2025 Market Overview & Low Risk Growth Stock Ideas - newser.com

02:39 AM
pulisher
01:41 AM

Full technical analysis of Outlook Therapeutics Inc. stockJuly 2025 Reactions & Safe Capital Preservation Plans - newser.com

01:41 AM
pulisher
Oct 22, 2025

What analyst consensus implies for Outlook Therapeutics Inc. (41O) stockWeekly Trading Summary & Pattern Based Trade Signal System - newser.com

Oct 22, 2025
pulisher
Oct 22, 2025

Outlook Therapeutics Inc. stock chart pattern explainedWatch List & Free Expert Verified Stock Movement Alerts - newser.com

Oct 22, 2025
pulisher
Oct 21, 2025

What drives Outlook Therapeutics Inc 41O stock priceAI-Driven Market Analysis & Consistent Double Returns - earlytimes.in

Oct 21, 2025
pulisher
Oct 21, 2025

What earnings margins imply for Outlook Therapeutics Inc. (41O) stockShare Buyback & Verified Trade Idea Suggestions - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Can Outlook Therapeutics Inc. stock continue upward trendJuly 2025 Big Picture & Weekly Market Pulse Updates - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Outlook Therapeutics Inc. (41ON) stock testing key supportJuly 2025 Intraday Action & Free Weekly Watchlist of Top Performers - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

What is the fair value of Outlook Therapeutics Inc. stock nowMarket Trend Report & Reliable Intraday Trade Plans - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

News impact scoring models applied to Outlook Therapeutics Inc.Portfolio Return Summary & Fast Gain Stock Trading Tips - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Published on: 2025-10-20 17:10:41 - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Is Outlook Therapeutics Inc. (41ON) stock attractive for growth funds2025 Market Overview & Long-Term Growth Portfolio Plans - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

What does recent volatility data suggest for Outlook Therapeutics Inc.Product Launch & Stepwise Trade Signal Implementation - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Will Outlook Therapeutics Inc. (41O) stock split increase liquidityJuly 2025 WrapUp & Smart Allocation Stock Tips - nchmf.gov.vn

Oct 20, 2025
pulisher
Oct 20, 2025

How Outlook Therapeutics Inc. stock performs in interest rate cyclesTreasury Yields & High Accuracy Trade Signal Alerts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Aug Retail: What analyst consensus implies for Outlook Therapeutics Inc. (41O) stockJuly 2025 Short Interest & Trade Opportunity Analysis Reports - nchmf.gov.vn

Oct 20, 2025
pulisher
Oct 19, 2025

Can Outlook Therapeutics Inc. rally from current levelsWeekly Trend Summary & Community Supported Trade Ideas - newser.com

Oct 19, 2025
pulisher
Oct 18, 2025

Can Outlook Therapeutics Inc. stock attract ESG capital inflows2025 Volume Leaders & Short-Term High Return Strategies - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Investment Review: Why Outlook Therapeutics Inc. stock could be next big winnerJuly 2025 Big Picture & Expert Verified Stock Movement Alerts - nchmf.gov.vn

Oct 18, 2025

Outlook Therapeutics Inc Stock (OTLK) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$36.85
price up icon 0.03%
$89.31
price up icon 1.42%
$29.87
price down icon 0.17%
$104.75
price down icon 1.39%
$160.12
price down icon 0.17%
biotechnology ONC
$310.03
price down icon 1.12%
Cap:     |  Volume (24h):